OUTLOOK Net Interest Income from 2010 to 2026
| OTLK Stock | USD 0.44 0.03 6.38% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter -49.4 K | Current Value -174.4 K | Quarterly Volatility 787.5 K |
Check OUTLOOK THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OUTLOOK THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.1 K, Interest Expense of 242.1 K or Selling General Administrative of 48.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 73.8 K or Days Sales Outstanding of 4.0E-4. OUTLOOK financial statements analysis is a perfect complement when working with OUTLOOK THERAPEUTICS Valuation or Volatility modules.
OUTLOOK | Net Interest Income | Build AI portfolio with OUTLOOK Stock |
Historical Net Interest Income data for OUTLOOK THERAPEUTICS serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether OUTLOOK THERAPEUTICS INC represents a compelling investment opportunity.
Latest OUTLOOK THERAPEUTICS's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of OUTLOOK THERAPEUTICS INC over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. OUTLOOK THERAPEUTICS's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OUTLOOK THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
OUTLOOK Net Interest Income Regression Statistics
| Arithmetic Mean | (1,790,097) | |
| Coefficient Of Variation | (77.86) | |
| Mean Deviation | 949,906 | |
| Median | (1,467,950) | |
| Standard Deviation | 1,393,705 | |
| Sample Variance | 1.9T | |
| Range | 5.4M | |
| R-Value | 0.30 | |
| Mean Square Error | 1.9T | |
| R-Squared | 0.09 | |
| Significance | 0.25 | |
| Slope | 81,899 | |
| Total Sum of Squares | 31.1T |
OUTLOOK Net Interest Income History
About OUTLOOK THERAPEUTICS Financial Statements
OUTLOOK THERAPEUTICS investors utilize fundamental indicators, such as Net Interest Income, to predict how OUTLOOK Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -222.4 K | -233.5 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of OUTLOOK THERAPEUTICS Correlation against competitors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. Anticipated expansion of OUTLOOK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive OUTLOOK THERAPEUTICS assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.79) | Revenue Per Share | Quarterly Revenue Growth 6.583 | Return On Assets | Return On Equity |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between OUTLOOK THERAPEUTICS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OUTLOOK THERAPEUTICS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OUTLOOK THERAPEUTICS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.